{
    "action": "final",
    "content": "## What This Dataset Is About\n\nThis is a **clinical trial adverse event tracking dataset** from a pharmaceutical study testing Xanomeline (an investigational drug). It captures safety monitoring data across 306 enrolled subjects who experienced 1,191 adverse events during the trial.\n\nThe dataset serves clinical trial safety monitors, medical reviewers, and regulatory specialists who need to:\n- Assess whether Xanomeline's safety profile supports advancing to the next trial phase\n- Identify adverse events requiring protocol amendments or additional monitoring\n- Detect differential safety signals across patient subgroups (age, race, sex)\n- Evaluate whether treatment discontinuation rates warrant dose adjustments\n- Monitor site-level adverse event reporting patterns for quality oversight\n\n## What a Single Row Represents\n\nThis dataset has **two distinct row types** across its two tables:\n\n### In `raw.ae` (1,191 rows — 80% of the dataset)\n**One row = one adverse event occurrence for one subject**\n\nEach row documents a single safety observation, identified by the combination of:\n- `USUBJID` (the subject experiencing the event)\n- `AESEQ` (the sequence number of this event for that subject)\n\nThese rows capture when the event started (`AESTDTC`), when it ended (`AEENDTC`), its medical classification (coded in `AEDECOD`, `AEBODSYS`, `AESOC`), severity, relationship to study drug (`AEREL`), and outcome. The 4:1 ratio of adverse events to subjects indicates an average of ~4 safety observations per enrolled participant.\n\n### In `raw.adsl` (306 rows — 20% of the dataset)\n**One row = one study subject**\n\nEach row represents a single enrolled individual, identified by `USUBJID`, with their:\n- Demographics (age, sex, race, country)\n- Treatment assignment (`ACTARM`, `ACTARMCD`)\n- Study participation dates (screening, randomization, treatment start/end)\n- Disposition outcomes (completion status, death information if applicable)\n\nThis table serves as the \"spine\" — the foundational roster of all 306 trial participants against which adverse events and other outcomes are analyzed.\n\n---\n\n**Important structural note**: While these tables are semantically related (adverse events belong to subjects), no technical join relationship was detected between them. Cross-table analysis requires manual linkage on `USUBJID`, which both tables carry as a person-identifying column that should only be used in aggregations, never quoted for individuals."
}